Baclofen in trigeminal neuralgia--a clinical trial.
Baclofen is a new antineuralgic drug. A clinical trial with treatment by this drug on 20 patients of trigeminal neuralgia was done. The action of this drug is similar to that of carbamazepine, however the former gives less undesirable side-effects. Out of 20 patients under treatment by this drug, 45% were relieved completely from pain while in 20% intensity and/or number of attacks of pain was reduced to half and in 35% effectiveness of Baclofen could not be observed.